drugset / Trial / NCT02742233
Dipeptidyl Peptidase 4 Inhibition Facilitate Healing of Diabetic Ulcers
RandomizedParallel-groupDouble-blindTreatment
Summary
To investigate the effect of Dipeptidyl Peptidase 4 Inhibition on wound healing in patients with diabetic foot ulcers, the investigators randomly divided the participants into two groups: saxagliptin with regular treatment group,placebo with regular treatment group. The clinical data are collected at the given time point. This study aimed to observe the potential protective effect of DPP4i on diabetic ulcers.
Timeline
- Start
- 2015-11
- Primary completion
- 2017-10
- Completion
- 2017-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SAXAGLIPTIN ANHYDROUS | Small molecule | 5 mg | Oral |